FP Notebook vs ASCCP Management Guidelines

Family Practice Notebook is a rapid access, point-of-care medical reference for primary care and emergency clinicians. Started in 1995, this collection now contains over 6100 interlinked topic pages divided into a tree of 31 specialty books and over 700 chapters. FP Notebook’s content is updated monthly with systematic literature reviews and conferences. Please purchase an auto-renewing subscription to receive the latest content. The text content for this mobile application is identical to its online counterparts: fpnotebook.com and fpnotebook.com/mobile. Although access to this application is not restricted, the information found here is intended for use by medical providers. Non-clinical users may find the material challenging to understand, and should address specific medical concerns with their medical providers. Try before you buy with a 14-day FREE trial. After that it's only $24.99/year for access, including continuous content updates. Privacy Policy/Terms & Conditions - http://www.fpnotebook.com/disclaimer.htm

The ASCCP Risk-Based Management Consensus Guidelines provide evidence-based recommendations for managing abnormal cervical cancer screening results and cancer precursors, including post-colposcopy and post-treatment scenarios. ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines. These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to: • Allow for a more complete and precise estimation of risk • Provide more appropriate intervention for high-risk individuals (detect and treat more precancer) • Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm) • Allow for the future addition of new risk modifiers and screening and management technologies See https://www.asccp.org/UserGuide for tips on using the app.